MorphoSys【MOR】株式ニュース

名称	銘柄コード	市場	種別
MorphoSys AG	MOR	NASDAQ	Depository Receipt

	前日比	前日比 %	現在値	時刻
	0.00	0.00%	18.18	05:30:00

始値	安値	高値	終値	前日終値
18.20	17.95	18.26	18.18	18.18

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/6/20	15:47	BW	MorphoSys and Novartis Sign Delisting Agreement and Intend..
2024/6/11	00:01	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/6/07	05:36	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/6/05	23:22	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/6/05	05:06	EDGAR2	Form SC 14D9/A - Solicitation, recommendation statements:..
2024/6/04	23:17	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/5/31	23:17	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/5/29	23:17	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/5/28	23:16	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/5/24	23:13	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/5/24	03:19	EDGAR2	Form SC 14D9/A - Solicitation, recommendation statements:..
2024/5/23	23:11	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/5/23	22:04	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/5/21	23:07	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/5/17	23:15	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/5/17	05:43	EDGAR2	Form SC 14D9/A - Solicitation, recommendation statements:..
2024/5/16	23:11	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/5/15	23:09	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/5/13	23:19	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/4/30	05:01	BW	MorphoSys AG Reports First Quarter 2024 Financial Results
2024/4/11	21:39	BW	MorphoSys’ Management Board and Supervisory Board Recommend..
2024/3/14	05:02	BW	MorphoSys AG Reports Fourth Quarter and Full Year 2023..
2024/2/06	20:14	IHMARKETNEWS	Boeing Faces Strike Threat, Palantir Up 18% After Recording..
2023/12/11	09:31	BW	MorphoSys’ Pelabresib Improves All Four Hallmarks of..
2023/11/21	07:19	DJN	MorphoSys Trial for Blood-Cancer Treatment Reaches Primary..
2023/11/21	06:30	BW	MorphoSys’ Phase 3 Study of Pelabresib in Myelofibrosis..
2023/11/16	06:01	BW	MorphoSys AG Reports First Nine Months and Third Quarter..
2023/8/10	05:01	BW	MorphoSys AG Reports Second Quarter and First Half 2023..